Rogue Pharmacies

November 25, 2019 by C. Scott McMillin

Don’t chains have quality control mechanisms to alert headquarters to abnormal patterns in prescription use?

Topics: , ,


Cannabis and Mental Health

November 18, 2019 by C. Scott McMillin

Even if it turns out to be ineffective for patients, buying cannabis products certainly gives a boost to the sales figures.

Topics: , ,


Truth Comes Out

October 28, 2019 by C. Scott McMillin

Some people are surprised that someone could function at such a high level in public despite significant drug use, but that’s something addiction has been known for.

Topics: , ,


“Addicted”? Or “dependent”?

October 10, 2019 by C. Scott McMillin

But it’s still confusing for many people outside the field, since unlike psychiatry, they don’t revise their thinking every couple decades.

Topics: , ,


Opioids in India

September 23, 2019 by C. Scott McMillin

As domestic sales decline, Big Pharma looks around for other markets

Topics: ,


Tricky Opioid Payouts

September 16, 2019 by C. Scott McMillin

I’m no lawyer, but it makes me think of robbing a bank and returning 20% of the spoils to avoid jail.

Topics: ,


Cheaters Do Get Caught…

August 5, 2019 by C. Scott McMillin

These multi-billion dollar fines sound enormous, but like the one levied on Facebook, they represent a small portion of the company’s actual assets.

Topics: , , ,


“Stay Tuned”

July 22, 2019 by C. Scott McMillin

Legal responsibility, however, is quite different. J&J’s attorneys will do whatever they can to shift blame elsewhere.

Topics: ,


Mission Not Accomplished

July 8, 2019 by C. Scott McMillin

It’s a real challenge for the folks on the ground to fit their reality into the prescribed format of a Federal grant.

Topics:


Esketamine Second Thoughts

July 4, 2019 by C. Scott McMillin

The first trials did not demonstrate effectiveness beyond placebo. So the FDA allowed a third trial which apparently did, at least a little.

Topics: ,


Subscribe to RecoverySI via Email


New Content